SNY (Sanofi) Other Current Liabilities : $15,842 Mil (As of Dec. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Sanofi Other Current Liabilities?

Sanofi's other current liabilities for the quarter that ended in Dec. 2024 was $15,842 Mil.

Sanofi's quarterly other current liabilities increased from Dec. 2023 ($13,764 Mil) to Jun. 2024 ($13,936 Mil) and increased from Jun. 2024 ($13,936 Mil) to Dec. 2024 ($15,842 Mil).

Sanofi's annual other current liabilities increased from Dec. 2022 ($11,370 Mil) to Dec. 2023 ($13,764 Mil) and increased from Dec. 2023 ($13,764 Mil) to Dec. 2024 ($15,842 Mil).

Sanofi Other Current Liabilities Historical Data

The historical data trend for Sanofi's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Other Current Liabilities Chart

Sanofi Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Liabilities

Get a 7-Day Free Trial

12,221.41

11,353.67

11,369.70

13,764.45

15,841.89

Sanofi Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Current Liabilities	Get a 7-Day Free Trial															11,369.70	13,118.09	13,764.45	13,936.49	15,841.89

Sanofi Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Sanofi Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Sanofi's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanofi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (NAS:SNY) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

SNYNF:USA SNY N:Mexico 1SAN:Italy 0A2V:UK SANp:UK 0O59:UK SAN:France SNW:Germany SNW2:Germany SNW:Germany SNW:Germany SNW2:Germany SNW:Germany SNW:Bulgaria SANO:Austria

Address

46, Avenue de la Great Army, Paris, FRA, 75017

Website

https://www.sanofi.com

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.